Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

Histopathology

Volumn 47, Issue 2, 2005, Pages 141-146

  Ryan, R ^a   Gibbons, D ^a   Hyland, J M P ^a   Treanor, D ^a   White, A ^a   Mulcahy, H E ^a   O'Donoghue, D P ^a   Moriarty, M ^a   Fennelly, D ^a   Sheahan, K ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Chemoradiotherapy; Pathological response; Rectal cancer; Tumour regression grade

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; REPRODUCIBILITY; SCORING SYSTEM; STANDARDIZATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 23444444903     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2005.02176.x     Document Type: Article

References (22)

1. Jemal A, Thomas A, Murray T et al. Cancer statistics, 2002. CA Cancer J. Clin. 2002; 52; 23-47.
2. Cancer facts and figures 2002. Atlanta, GA: American Cancer Society.
3. Nelson H, Petrelli N, Carlin A et al. Guidelines 2000 for colon and rectal cancer surgery. J. Natl Cancer Inst. 2001; 93; 583-596.
4. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl J. Med. 2001; 345; 638-646.
5. Kapiteijn E, van de Velde CJ. The role of total mesorectal excision in the management of rectal cancer. Surg. Clin. North Am. 2002; 82; 995-1007.
6. Pahlman L, Glimelius B. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N. Engl. J. Med. 1997; 336; 980-987.
7. Ruo L, Tickoo S, Klimstra DS et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann. Surg. 2002; 236; 75-81.
8. Minsky B, Cohen A, Enker W et al. Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer. Cancer 1994; 73; 273-280.
9. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int. J. Colorectal Dis. 1997; 12; 19-23.
10. McNicholas MM, Joyce WP, Dolan J et al. Magnetic resonance imaging of rectal carcinoma: a prospective study. Br. J. Surg. 1994; 81; 911-914.
11. Quirke P, Durdey P, Dixon MF et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986; 2; 996-999.
12. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73; 2680-2686.
13. Bouzourene H, Bosman FT, Seelentag W et al. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002; 94; 1121-1130.
14. Williamson PR, Hellinger MD, Larach SW et al. Endorectal ultrasound of T3 and T4 rectal cancers after preoperative chemoradiation. Dis. Colon Rectum 1996; 39; 45-49.
15. Wheeler JM, Warren BF, Jones AC et al. Preoperative radiotherapy for rectal cancer: implications for surgeons, pathologists and radiologists. Br. J. Surg. 1999; 86; 1108-1120.
16. Shia J, Guillem JG, Moore HG et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am. J. Surg. Pathol. 2004; 28; 215-223.
17. Greene F, Page D, Fleming I et al. AJCC cancer staging manual, 6th edn. 2002. New York: Springer.
18. Reynolds JV, Joyce WP, Dolan J et al. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br. J. Surg. 1996; 83; 1112-1115.
19. Bozzetti F, Andreola S, Rossetti C et al. Preoperative radiotherapy for resectable cancer of the middle-distal rectum: its effect on the primary lesion as determined by endorectal ultrasound using flexible echo colonoscope. Int. J. Colorectal Dis. 1996; 11; 283-286.
20. Meade PG, Blatchford GJ, Thorson AG et al. Preoperative chemoradiation downstages locally advanced ultrasound-staged rectal cancer. Am. J. Surg. 1995; 170; 609-612.
21. Sanchez W, Luna-Perez P, Alvarado I et al. Modified clearing technique to identify lymph node metastases in post-irradiated surgical specimens from rectal adenocarcinoma. Arch. Med. Res. 1996; 27; 31-36.
22. Wheeler JM, Warren BF, Mortensen NJ et al. Quantification of histologic regression of rectal cancer after irradiation: a proposal for a modified staging system. Dis. Colon Rectum 2002; 45; 1051-1056.